Vistin Pharma ASA Capital Reinvestment Ratio
Vistin Pharma ASA capital reinvestment ratio. Vistin Pharma ASA (VISTN) has a Capital Reinvestment Ratio of 0.16x as of December 2025, meaning it reinvests 0% of its operating cash flow (Nkr40.81 Million) in capital expenditures (Nkr6.51 Million). Check how aggressively does Vistin Pharma ASA reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Vistin Pharma ASA (2016–2025)
Capital reinvestment ratio of Vistin Pharma ASA from 2016 to 2025. This chart tracks Vistin Pharma ASA's Capital Reinvestment Ratio across 7 annual periods. Also explore net asset momentum of Vistin Pharma ASA to track the company's year-over-year net asset growth rate.
Vistin Pharma ASA Capital Reinvestment Ratio by Year (2016–2025)
Vistin Pharma ASA capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see VISTN cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | Nkr78.04 Million | Nkr16.68 Million | ▼ -43.5% |
| 2024 | 0.38x | Nkr107.86 Million | Nkr40.80 Million | ▲ +91.5% |
| 2023 | 0.20x | Nkr90.59 Million | Nkr17.90 Million | ▼ -91.5% |
| 2021 | 2.33x | Nkr13.68 Million | Nkr31.94 Million | ▲ +140.8% |
| 2019 | 0.97x | Nkr18.93 Million | Nkr18.36 Million | ▼ -74.1% |
| 2017 | 3.74x | Nkr9.51 Million | Nkr35.55 Million | ▲ +1136.9% |
| 2016 | 0.30x | Nkr53.84 Million | Nkr16.27 Million | — |